CARCINOID CANCER FOUNDATION (EIN 136277875) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1968

Legal Domicile

Principal Officer

KEITH WARNER

Phone

9146831001

Tax Period

2024-03-01 to 2025-02-28

CARCINOID CANCER FOUNDATION, founded in 1968, is a small nonprofit in the Medical Research sector that reported $253K in total revenue in fiscal year 2024. Revenue surged 28% from the prior year, signaling strong growth momentum. Expenses of $362K exceeded revenue, resulting in a 43% operating deficit.

Mission

ORGANIZATION MISSION: TO PROVIDE EDUCATION AND AWARENESS INFORMATION TO PATIENTS AND FAMILIES OF PATIENTS IMPACTED BY CARCINOID AND NEUROENDOCRINE TUMORS, AS WELL AS TO SERVE AS ADVOCATES THROUGHOUT THE COMMUNITY CONNECTING PHYSICIANS, CAREGIVERS, PATIENTS, FAMILIES OF PATIENTS AND THOSE ORGANIZATIONS SERVING THE COMMUNITY WITH DIAGNOSTIC TOOLS AND METHODS AS WELL AS THOSE PROVIDING TREATMENT.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2024)

Revenue Breakdown

Contributions & Grants $258,576

Program Service Revenue $0

Investment Income $-5,377

Other Revenue $0

TOTAL REVENUE $253,199

Expense Breakdown

Grants Paid $0

Salaries & Benefits $219,057

Fundraising Expenses $33,480

Program Expenses $179,646

Other Expenses $143,138

TOTAL EXPENSES $362,195

Year-over-Year Comparison

	2024	2023	Change
Revenue	$253,199	$197,343	+0.3%
Expenses	$362,195	$373,195	0.0%
Net Income	$-108,996	$-175,852	-0.4%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$125,000

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
BRIAN THEDE	DIR/BOARD MEMBER	0.25	Director	$0	$0	$0
STEVEN MUELLER	DIRECTOR/BOARD MEMBE	0.25	Director	$0	$0	$0
KEITH WARNER	CEO/CHAIRMAN/TREASURER	40.00	Officer	$125,000	$0	$125,000

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2025	$253,199	$362,195	$597,207	$-108,996
2024	$197,343	$373,195	$701,203	$-175,852
2023	$434,109	$485,972	$880,761	$-51,863
2022	$461,567	$422,645	$938,466	$38,922
2021	$405,113	$502,219	$889,113	$-97,106
2020	$504,363	$456,577	$985,604	$47,786
2019	$557,464	$480,559	$939,661	$76,905

CARCINOID CANCER FOUNDATION